Skip to main content
Erschienen in: Clinical and Translational Oncology 9/2019

14.02.2019 | Research Article

Laparoscopic cytoreductive surgery and HIPEC is effective regarding peritoneum tissue paclitaxel distribution

verfasst von: D. Padilla-Valverde, P. Villarejo, J. Redondo, J. Oyarzabal, A. Estella, T. Palomino, E. Fernandez, S. Sanchez, S. Sánchez, P. Faba, V. Baladron, A. Alberca, O. Montenegro, J. Fernández, P. Marta, J. Martín

Erschienen in: Clinical and Translational Oncology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

In some patients with peritoneal carcinomatosis, we could perform the cytoreductive surgery and the HIPEC procedure by a complete laparoscopic approach to avoid morbidity. We consider that using laparoscopic approach for performing peritoneal carcinomatosis cytoreductive surgery and HIPEC with closed CO2 recirculation technique is possible and safe, with equal efficacy to conventional methods and hemodynamic complications.

Objective

Monitoring the effectiveness of the drug distribution in a laparoscopic ctoreductive and HIPEC surgery group with CO2 recirculation respect to a closed and open HIPEC group

Methods

Porcine model that included fifteen mini-pigs. Five pigs were operated with laparoscopic approach performing a pelvic and retroperitoneal lymphadenectomy. They later received a total laparoscopic closed HIPEC with CO2 recirculation (G1). Group 2 (G2): five pigs operated by an open cytoreductive surgery and closed HIPEC technique. Group 3 (G3): five animals in which an open cytoreductive surgery and an open HIPEC technique was performed. Blood and peritoneal determinations were realized after recirculation of the drug, at 60 min using chromatographic analysis.

Results

G1–G2: phrenic right peritoneum, p: 0.46. Phrenic left peritoneum, p: 0.46. Pelvic peritoneum, p: 0.17. Serum paclitaxel: p: 0.01. G1–G3: phrenic right peritoneum, p: 0.34. Phrenic left peritoneum, p: 0.34. Pelvic peritoneum, p: 0.17. Serum paclitaxel G1–G3, p: 0.02.

Conclusions

A total laparoscopic approach for ctoreductive surgery and closed HIPEC with CO2 recirculation may be safe and feasible. In our experimental model there was no significant difference in tissue drug distribution respect the conventional techniques and there was a less toxicity because the serum drug concentration was significantly lower with laparoscopic approach respect the other groups.
Literatur
1.
Zurück zum Zitat Pelz JO, Vetterlein M, Grimmig T, Grimmiq T, Kerscher AG, Moll E, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol. 2013;20:1105–13.CrossRefPubMed Pelz JO, Vetterlein M, Grimmig T, Grimmiq T, Kerscher AG, Moll E, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol. 2013;20:1105–13.CrossRefPubMed
2.
Zurück zum Zitat Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res. 1984;44:605–12.PubMed Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res. 1984;44:605–12.PubMed
3.
Zurück zum Zitat Overgaard J. Effect of hyperthermia on malignant cells in vivo: a review and a hypothesis. Cancer. 1977;39:2637–46.CrossRefPubMed Overgaard J. Effect of hyperthermia on malignant cells in vivo: a review and a hypothesis. Cancer. 1977;39:2637–46.CrossRefPubMed
4.
Zurück zum Zitat Hildebrandt B, Wust P, Ahlers O, Dieing A, Screenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43:33–56.CrossRefPubMed Hildebrandt B, Wust P, Ahlers O, Dieing A, Screenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002;43:33–56.CrossRefPubMed
5.
Zurück zum Zitat El-Kareh AW, Secomb TW. A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia. 2004;6:117–27.CrossRefPubMedPubMedCentral El-Kareh AW, Secomb TW. A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia. 2004;6:117–27.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Konigsrainer I, Beckert S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: where are we? World J Gastroenterol. 2012;18:5317–20.CrossRefPubMedPubMedCentral Konigsrainer I, Beckert S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: where are we? World J Gastroenterol. 2012;18:5317–20.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, et al. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol. 2008;15(98):242–6.CrossRef Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, et al. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol. 2008;15(98):242–6.CrossRef
8.
Zurück zum Zitat Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol. 2007;18:1943–50.CrossRefPubMed Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol. 2007;18:1943–50.CrossRefPubMed
9.
Zurück zum Zitat Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbaq G, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790–6.CrossRefPubMed Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbaq G, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790–6.CrossRefPubMed
10.
Zurück zum Zitat Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15:339–44.CrossRefPubMed Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15:339–44.CrossRefPubMed
11.
Zurück zum Zitat Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon‘s role. Langenbecks Arch Surg. 1999;384:576–87.CrossRefPubMed Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon‘s role. Langenbecks Arch Surg. 1999;384:576–87.CrossRefPubMed
12.
Zurück zum Zitat Simon L, Halilou MC, Gladieff L, Gadiou M, Herin F, Hennebelle I, et al. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel. Bull Cancer. 2009;96:971–7.CrossRef Simon L, Halilou MC, Gladieff L, Gadiou M, Herin F, Hennebelle I, et al. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel. Bull Cancer. 2009;96:971–7.CrossRef
13.
Zurück zum Zitat Sugarbaker PH. An Instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol. 2005;92:142–6.CrossRefPubMed Sugarbaker PH. An Instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol. 2005;92:142–6.CrossRefPubMed
14.
Zurück zum Zitat Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863–9.CrossRefPubMed Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863–9.CrossRefPubMed
15.
Zurück zum Zitat Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144–53.CrossRefPubMed Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144–53.CrossRefPubMed
16.
Zurück zum Zitat Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol. 2010;17:1957–63.CrossRefPubMed Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol. 2010;17:1957–63.CrossRefPubMed
17.
Zurück zum Zitat Raspe C, Piso P, Wiesenack C, Bucher M. Anesthetic management in patients undergoing hyperthermic chemotherapy. Curr Opin Anesthesiol. 2012;25:348–55.CrossRef Raspe C, Piso P, Wiesenack C, Bucher M. Anesthetic management in patients undergoing hyperthermic chemotherapy. Curr Opin Anesthesiol. 2012;25:348–55.CrossRef
18.
Zurück zum Zitat Eichhorn V, Goepfert MS, Eulenburg C, Malbrain ML, Reuter DA. Comparison of values in critically ill patients for global end-diastolic volume and extravascular lung water measured by transcardiopulmonary thermodilution: a meta-analysis of the literature. Med Intensiva. 2012;36:467–74.CrossRefPubMed Eichhorn V, Goepfert MS, Eulenburg C, Malbrain ML, Reuter DA. Comparison of values in critically ill patients for global end-diastolic volume and extravascular lung water measured by transcardiopulmonary thermodilution: a meta-analysis of the literature. Med Intensiva. 2012;36:467–74.CrossRefPubMed
19.
Zurück zum Zitat Huber W, Umgelter A, Reindl W, Franzen M, Schmidt C, von Delius S, et al. Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volumen index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water. Crit Care Med. 2008;36:2348–54.CrossRefPubMed Huber W, Umgelter A, Reindl W, Franzen M, Schmidt C, von Delius S, et al. Volume assessment in patients with necrotizing pancreatitis: a comparison of intrathoracic blood volumen index, central venous pressure, and hematocrit, and their correlation to cardiac index and extravascular lung water. Crit Care Med. 2008;36:2348–54.CrossRefPubMed
20.
Zurück zum Zitat Costa MG, Chiarandini P, Rocca D. Hemodynamics during liver transplantation. Transplant Proc. 2007;39:1871–3.CrossRefPubMed Costa MG, Chiarandini P, Rocca D. Hemodynamics during liver transplantation. Transplant Proc. 2007;39:1871–3.CrossRefPubMed
21.
Zurück zum Zitat Della Rocca G, Costa MG, Pompei G, Coccia C, Pitropaoli P. Continuous and intermittent cardiac output measurement: pulmonary artery catheter versus aortic transpulmonary technique. Br J Anaesth. 2002;88:350–6.CrossRefPubMed Della Rocca G, Costa MG, Pompei G, Coccia C, Pitropaoli P. Continuous and intermittent cardiac output measurement: pulmonary artery catheter versus aortic transpulmonary technique. Br J Anaesth. 2002;88:350–6.CrossRefPubMed
22.
Zurück zum Zitat Feltracco P, Biancofiore G, Ori C, Saner FH, Della Rocca G. Limits and pitfalls of haemodynamic monitoring systems in liver transplantation surgery. Minerva Anastesiol. 2012;78:1372–84. Feltracco P, Biancofiore G, Ori C, Saner FH, Della Rocca G. Limits and pitfalls of haemodynamic monitoring systems in liver transplantation surgery. Minerva Anastesiol. 2012;78:1372–84.
23.
Zurück zum Zitat Rothfield KP, Crowley K. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surg Oncol Clin N Am. 2012;21:533–41.CrossRefPubMed Rothfield KP, Crowley K. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surg Oncol Clin N Am. 2012;21:533–41.CrossRefPubMed
24.
Zurück zum Zitat Facchiano E, Risio D, Kianmanesh R, Msika S. Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims and results. A systematic review of the literature. Ann Surg Oncol. 2012;19:2946–50.CrossRef Facchiano E, Risio D, Kianmanesh R, Msika S. Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims and results. A systematic review of the literature. Ann Surg Oncol. 2012;19:2946–50.CrossRef
25.
Zurück zum Zitat Sloothaak DAM, Gardenbroek TJ, Crezee J, Bemelman WA, Punt CJ, Buskens CJ, et al. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis. EJSO. 2014;40:1453–8.CrossRefPubMed Sloothaak DAM, Gardenbroek TJ, Crezee J, Bemelman WA, Punt CJ, Buskens CJ, et al. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis. EJSO. 2014;40:1453–8.CrossRefPubMed
26.
Zurück zum Zitat Esquivel J, Averbach A, Chua TC. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surfaces malignancies. Ann Surg. 2011;253:764–8.CrossRef Esquivel J, Averbach A, Chua TC. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surfaces malignancies. Ann Surg. 2011;253:764–8.CrossRef
27.
Zurück zum Zitat Lotti M, Capponi MG, Piazzalunga D, Poiasina E, Pisano M, Manfredi R, et al. Laparoscopic HIPEC: a bridge between open and closed techniques. J Minim Acces Surg. 2016;12:86–9.CrossRef Lotti M, Capponi MG, Piazzalunga D, Poiasina E, Pisano M, Manfredi R, et al. Laparoscopic HIPEC: a bridge between open and closed techniques. J Minim Acces Surg. 2016;12:86–9.CrossRef
28.
Zurück zum Zitat Sánchez García S, Padilla Valverde D, Villarejo Campos P, Martin-Fernandez J, Garcia-Rojo M, Rodriguez-Martinez M. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat® CO2 recirculation system. Surgery. 2014;155(4):719–25.CrossRefPubMed Sánchez García S, Padilla Valverde D, Villarejo Campos P, Martin-Fernandez J, Garcia-Rojo M, Rodriguez-Martinez M. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat® CO2 recirculation system. Surgery. 2014;155(4):719–25.CrossRefPubMed
29.
Zurück zum Zitat Sánchez García S, Villarejo Campos P, Padilla Valverde D, Amo-Salas M, Martin-Fernandez J. Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed-abdomen technique (Combat PRS-1.0): a clinical pilot study. Int J Hyperth. 2016;32(5):488–98.CrossRef Sánchez García S, Villarejo Campos P, Padilla Valverde D, Amo-Salas M, Martin-Fernandez J. Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed-abdomen technique (Combat PRS-1.0): a clinical pilot study. Int J Hyperth. 2016;32(5):488–98.CrossRef
30.
Zurück zum Zitat Padilla-Valverde D, Sanchez-Garcia S, García-Santos E, Marcote-Ibañez C, Molina-Robles M, Martin-fernandez J, et al. Usefulness of thermographic analysis to control temperature homogeneity in the development and implementation of a closed recirculating CO2 chemohyperthermia model. Int J Hyperth. 2016;30:1–7. Padilla-Valverde D, Sanchez-Garcia S, García-Santos E, Marcote-Ibañez C, Molina-Robles M, Martin-fernandez J, et al. Usefulness of thermographic analysis to control temperature homogeneity in the development and implementation of a closed recirculating CO2 chemohyperthermia model. Int J Hyperth. 2016;30:1–7.
31.
Zurück zum Zitat García-Santos EP, Padilla-Valverde D, Villarejo-Campos P, Murillo-Lazaro C, Fernandez-grande E, Palomino-Muñoz T, et al. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR10. Pancreatology. 2016;16(4):632–9.CrossRefPubMed García-Santos EP, Padilla-Valverde D, Villarejo-Campos P, Murillo-Lazaro C, Fernandez-grande E, Palomino-Muñoz T, et al. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR10. Pancreatology. 2016;16(4):632–9.CrossRefPubMed
32.
Zurück zum Zitat Pascual-Ramírez J, Sánchez-García S, González-Ruizdelaherrán F, Villarejo-Campos P, LopezdelaManzanara C, Haya-Palazuelo J, et al. Security and efficiency of a closed-system, turbulent-flow circuit for hyperthermic intraperitoneal chemotherapy after cytoreductive ovarian surgery: perioperative outputs. Arch Gynecol Obstet. 2014;290:121–9.CrossRefPubMed Pascual-Ramírez J, Sánchez-García S, González-Ruizdelaherrán F, Villarejo-Campos P, LopezdelaManzanara C, Haya-Palazuelo J, et al. Security and efficiency of a closed-system, turbulent-flow circuit for hyperthermic intraperitoneal chemotherapy after cytoreductive ovarian surgery: perioperative outputs. Arch Gynecol Obstet. 2014;290:121–9.CrossRefPubMed
33.
Zurück zum Zitat Sanchez-García S, Padilla-Valverde D, Villarejo-Campos P, Garcia-santos E, Martin-Fernandez J. Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis. Int J Hyperth. 2017;33:684–9.CrossRef Sanchez-García S, Padilla-Valverde D, Villarejo-Campos P, Garcia-santos E, Martin-Fernandez J. Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis. Int J Hyperth. 2017;33:684–9.CrossRef
34.
Zurück zum Zitat Facy O, Al Samman S, Magnin G, Ghiringhelli F, Ladoire S, Chauffert B, et al. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg. 2012;256:1084–8.CrossRefPubMed Facy O, Al Samman S, Magnin G, Ghiringhelli F, Ladoire S, Chauffert B, et al. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg. 2012;256:1084–8.CrossRefPubMed
35.
Zurück zum Zitat Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study. Ann Surg. 2011;254:125–30.CrossRefPubMed Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study. Ann Surg. 2011;254:125–30.CrossRefPubMed
36.
Zurück zum Zitat Piche N, Leblond FA, Sidéris L, Pichette V, Drolet P, Fotier LP, et al. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis. A study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann Surg. 2011;254:138–44.CrossRefPubMed Piche N, Leblond FA, Sidéris L, Pichette V, Drolet P, Fotier LP, et al. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis. A study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann Surg. 2011;254:138–44.CrossRefPubMed
37.
Zurück zum Zitat Esquis P, Consolo D, Margin D, Pointaire P, Moretto P, Ynsa MD, et al. High intrabdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244:106–12.CrossRefPubMedPubMedCentral Esquis P, Consolo D, Margin D, Pointaire P, Moretto P, Ynsa MD, et al. High intrabdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244:106–12.CrossRefPubMedPubMedCentral
Metadaten
Titel
Laparoscopic cytoreductive surgery and HIPEC is effective regarding peritoneum tissue paclitaxel distribution
verfasst von
D. Padilla-Valverde
P. Villarejo
J. Redondo
J. Oyarzabal
A. Estella
T. Palomino
E. Fernandez
S. Sanchez
S. Sánchez
P. Faba
V. Baladron
A. Alberca
O. Montenegro
J. Fernández
P. Marta
J. Martín
Publikationsdatum
14.02.2019
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 9/2019
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02052-8

Weitere Artikel der Ausgabe 9/2019

Clinical and Translational Oncology 9/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.